Dynavax to Present at the RBC Capital Markets Global Healthcare Conference
February 14 2018 - 8:00AM
Dynavax Technologies Corporation (NASDAQ:DVAX) announced today that
Eddie Gray, Dynavax’s chief executive officer,
will participate in a fireside chat at the 2018 RBC Capital
Markets Global Healthcare Conference in New York City. The
presentation will be webcast live and will occur on Wednesday,
February 21, 2018 at 1:35 p.m. ET.
The live or replayed versions of the webcast will be available
by visiting the “Investors” section of the Dynavax website at
www.dynavax.com.
About DynavaxDynavax is a
commercial-stage biopharmaceutical company focused on leveraging
the power of the body's innate and adaptive immune responses
through toll-like receptor (TLR) stimulation. Dynavax discovers and
develops novel vaccines and immuno-oncology therapeutics. The
Company's first commercial product, HEPLISAV-B™ [Hepatitis B
Vaccine (Recombinant), Adjuvanted], is approved in the United
States. Dynavax's lead immunotherapy product, SD-101, is an
investigational cancer immunotherapeutic currently being evaluated
in Phase 1/2 studies and its second cancer immunotherapeutic,
DV281, is in Phase 1 development. For more information, visit
www.dynavax.com.
Contact:
David BurkeDirector, Investor Relations & Corporate
Communications510.665.7269dburke@dynavax.com
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Apr 2024 to May 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From May 2023 to May 2024